Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C and IDL by using middle dose Rosuvastatin in Saitama.

Next Previous
X
Search
Trial Profile

Trial against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C and IDL by using middle dose Rosuvastatin in Saitama.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms PIONEER-Saitama

    • Most Recent Events

    • 27 Sep 2017 Planned number of patients changed from 90 to 200.
    • 23 Jan 2014 Status changed to completed as per University Hospital Medical Information Network - Japan.
    • 18 Sep 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top